Cel-Sci (LSR) Financial Statements
Cel-Sci Financial Overview
Cel-Sci's market cap is currently $21.66M. The company's EPS TTM is $-2.58; its P/E ratio is -0.53; Cel-Sci has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -15.89M | $ -3.97M | $ -22.47M | $ 0.00 | $ 0.00 |
| Operating Income | $ -24.81M | $ -26.35M | $ -31.48M | $ -36.06M | $ -36.19M |
| EBITDA | $ -20.88M | $ -22.21M | $ -27.52M | $ -31.79M | $ -32.98M |
| Net Income | $ -25.41M | $ -26.92M | $ -32.37M | $ -36.70M | $ -36.36M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.95M | $ 4.74M | $ 4.15M | $ 22.67M | $ 42.21M |
| Total Assets | $ 28.16M | $ 26.99M | $ 30.53M | $ 50.52M | $ 75.87M |
| Total Debt | $ 9.38M | $ 11.62M | $ 13.57M | $ 15.30M | $ 15.97M |
| Net Debt | $ -1.57M | $ 6.88M | $ 9.43M | $ -7.37M | $ -20.09M |
| Total Liabilities | $ 12.20M | $ 14.12M | $ 17.31M | $ 18.36M | $ 19.34M |
| Stockholders' Equity | $ 15.96M | $ 12.87M | $ 13.21M | $ 32.16M | $ 56.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -17.16M | $ -18.91M | $ -23.22M | $ -18.88M | $ -27.83M |
| Operating Cash Flow | $ -17.12M | $ -18.81M | $ -22.85M | $ -18.24M | $ -18.79M |
| Investing Cash Flow | $ -38.11K | $ -108.09K | $ -372.26K | $ 5.49M | $ -15.18M |
| Financing Cash Flow | $ 23.37M | $ 19.51M | $ 4.69M | $ -638.43K | $ 54.52M |
Currency in USD